1874 related articles for article (PubMed ID: 30367835)
1. Epidemiology and Management of Hepatocellular Carcinoma.
Kulik L; El-Serag HB
Gastroenterology; 2019 Jan; 156(2):477-491.e1. PubMed ID: 30367835
[TBL] [Abstract][Full Text] [Related]
2. The Epidemiology of Hepatocellular Carcinoma in the USA.
Kim HS; El-Serag HB
Curr Gastroenterol Rep; 2019 Apr; 21(4):17. PubMed ID: 30976932
[TBL] [Abstract][Full Text] [Related]
3. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
Meringer H; Shibolet O; Deutsch L
World J Gastroenterol; 2019 Aug; 25(29):3929-3940. PubMed ID: 31413528
[TBL] [Abstract][Full Text] [Related]
5. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G
World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428
[TBL] [Abstract][Full Text] [Related]
6. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
Perumpail RB; Wong RJ; Ahmed A; Harrison SA
Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
[TBL] [Abstract][Full Text] [Related]
8. Changing Epidemiology of Hepatocellular Carcinoma Within the United States and Worldwide.
Rich NE
Surg Oncol Clin N Am; 2024 Jan; 33(1):1-12. PubMed ID: 37945136
[TBL] [Abstract][Full Text] [Related]
9. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.
Mak LY; Cruz-Ramón V; Chinchilla-López P; Torres HA; LoConte NK; Rice JP; Foxhall LE; Sturgis EM; Merrill JK; Bailey HH; Méndez-Sánchez N; Yuen MF; Hwang JP
Am Soc Clin Oncol Educ Book; 2018 May; 38():262-279. PubMed ID: 30231359
[TBL] [Abstract][Full Text] [Related]
10. Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B.
Lee YB; Ha Y; Chon YE; Kim MN; Lee JH; Park H; Kim KI; Kim SH; Rim KS; Hwang SG
Clin Mol Hepatol; 2019 Mar; 25(1):52-64. PubMed ID: 30360031
[TBL] [Abstract][Full Text] [Related]
11. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
[TBL] [Abstract][Full Text] [Related]
12. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
Kim NG; Nguyen PP; Dang H; Kumari R; Garcia G; Esquivel CO; Nguyen MH
Cancer; 2018 Jun; 124(12):2588-2598. PubMed ID: 29624631
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
[TBL] [Abstract][Full Text] [Related]
14. Current treatment for hepatocellular carcinoma.
Cahill BA; Braccia D
Clin J Oncol Nurs; 2004 Aug; 8(4):393-9. PubMed ID: 15354926
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and management of hepatocellular carcinoma.
Yang JD; Roberts LR
Infect Dis Clin North Am; 2010 Dec; 24(4):899-919, viii. PubMed ID: 20937457
[TBL] [Abstract][Full Text] [Related]
16. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
17. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.
Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S
Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335
[TBL] [Abstract][Full Text] [Related]
18. Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma: A Growing Epidemic?
Yopp AC; Choti MA
Dig Dis; 2015 Sep; 33(5):642-7. PubMed ID: 26398208
[TBL] [Abstract][Full Text] [Related]
19. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
Bertot LC; Adams LA
Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
[TBL] [Abstract][Full Text] [Related]
20. Rising incidence and demographics of hepatocellular carcinoma in the USA: what does it mean?
Shaw JJ; Shah SA
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):365-70. PubMed ID: 21651354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]